Skip to main content
Aplisens S.A. logo

Aplisens S.A. — Investor Relations & Filings

Ticker · APN ISIN · PLAPLS000016 LEI · 259400OT63WADN2FBI37 WAR Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2017-05-30 Notice of Dividend Amou…
Country PL Poland
Listing WAR APN

About Aplisens S.A.

https://aplisens.com/

Aplisens S.A. is a manufacturer of high-quality process instrumentation and industrial measurement equipment. The company specializes in a wide range of devices for measuring pressure, differential pressure, level, flow, and temperature. Its product portfolio includes pressure transmitters, sensors, and other control instruments designed for various industrial applications that require precise process monitoring and control. The company serves a global customer base across numerous sectors, offering comprehensive solutions for industrial automation and control systems.

Recent filings

Filing Released Lang Actions
Podjęcie przez Zwyczajne Walne Zgromadzenie Spółki uchwały w sprawie dywidendy - Content (PL)
Notice of Dividend Amount Classification · 98% confidence The document text, written in Polish, explicitly discusses the resolutions passed by the Ordinary General Meeting ('Zwyczajne Walne Zgromadzenie') on May 30, 2017, specifically resolution number 13c regarding the allocation of the net profit for 2016. The resolution details the distribution of profit into reserve capital and the payment of a dividend ('wypłatę dywidendy') of PLN 0.30 per share, setting the record date and payment date. Since the core subject is the formal decision on dividend distribution made by the General Meeting, this aligns best with the 'Notice of Dividend Amount' (DIV). Although it originates from an AGM, the specific content is the dividend declaration, not general AGM materials (AGM-R) or a proxy statement (PSI).
2017-05-30 Polish
Informacja Zarządu art.363 KSH
Transaction in Own Shares Classification · 99% confidence The document is titled "Załącznik do projektu uchwały nr 14 Zwyczajnego Walnego Zgromadzenia APLISENS S.A." (Attachment to the draft resolution No. 14 of the Annual General Meeting of APLISENS S.A.) and specifically details the 'Informacja Zarządu' (Management Information) regarding the 'przyczynach lub celu nabycia własnych akcji' (reasons or purpose of acquiring own shares), the number, nominal value, and consideration paid. This content directly relates to the company buying back or selling its own shares (share repurchase/issuance). This aligns perfectly with the definition for Transaction in Own Shares (POS). Although it is an attachment to an AGM resolution, the core subject matter is the share transaction itself.
2017-05-25 Polish
Sprawozdanie z działalności RN APLISENS w 2016 roku
Board/Management Information Classification · 99% confidence The document is titled "Sprawozdanie z działalności Rady Nadzorczej APLISENS S.A. w 2016 roku" (Report on the activities of the Supervisory Board of APLISENS S.A. in 2016). It details the composition of the Supervisory Board, its meetings, resolutions, oversight activities, and compliance with corporate governance principles (like GPW 2016 Best Practices) throughout the year 2016. This content directly relates to the internal rules, board structure, and governance practices of the company, which aligns perfectly with the definition of Governance Information (CGR). It is not a general Annual Report (10-K), an Audit Report (AR), or a simple announcement of a report (RPA/RNS), but the report itself detailing governance activities.
2017-05-25 Polish
Sprawozdanie RN z wyników oceny sytuacji Spółki w 2016 roku
Governance Information Classification · 99% confidence The document is titled "Sprawozdanie Rady Nadzorczej" (Report of the Supervisory Board) and details the results of the assessment of APLISENS S.A.'s situation in 2016, specifically covering internal control systems, risk management, compliance, internal audit function, and corporate governance obligations. It includes a review of the 2016 financial results (P&L, Balance Sheet, Cash Flow) and the Board's assessment of management's performance and future risks. This content strongly aligns with the requirements for a comprehensive annual review document, often associated with corporate governance and oversight, which falls under the scope of Governance Information (CGR) or potentially a component of an Annual Report (10-K). However, since it is specifically a report from the Supervisory Board assessing internal controls and governance practices, and not the primary financial filing (10-K) or a general Audit Report (AR), the most precise fit among the provided codes is Governance Information (CGR), as it heavily focuses on internal rules, board structure assessment, and compliance with corporate governance codes (Dobrych Praktyk Spółek Notowanych na GPW 2016). The length (29,466 chars) confirms it is a substantial report, not a mere announcement (RPA/RNS).
2017-05-25 Polish
Sprawozdania Rady Nadzorczej APLISENS S.A. przedkładane Zwyczajnemu Walnemu Zgromadzeniu Spółki oraz informacja Zarządu zgodna z art.363 par.1 KSH - Content (PL)
Report Publication Announcement Classification · 98% confidence The document is a current report (raport bieżący nr 21/2017) from the Management Board (Zarząd) of APLISENS S.A. It announces the submission of reports from the Supervisory Board (Rada Nadzorcza) to the Annual General Meeting (Zwyczajne Walne Zgromadzenie) scheduled for May 30, 2017. The submitted documents include the Supervisory Board's report on activities for 2016 and a report on the assessment of the company's situation, internal controls, and governance. It also mentions information regarding the acquisition of own shares to be presented at the AGM. Since the document's primary function is to announce the publication/submission of reports and related materials intended for the AGM, and given its short length (1164 chars), it fits the description of a Report Publication Announcement (RPA). It is not the full AGM material (AGM-R) or the full reports themselves (like 10-K or AR).
2017-05-25 Polish
Rejestracja spółki zależnej APLISENS Middle Asia w Kazachstanie - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is written in Polish and discusses the establishment of a new subsidiary, APLISENS Middle Asia, in Kazakhstan. It details the capital structure (20,000,000 KZE), ownership split (50% by APLISENS S.A. and 50% by SOOO "APLISENS"), and the strategic purpose (increasing sales in Kazakhstan). This action—creating a new entity as part of a strategic plan—falls under corporate financing, capital structure changes, or significant business transactions. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit as it involves the formation and capitalization of a new entity, which is a form of capital activity. It is not a standard regulatory filing like 10-K or IR, nor is it a management change or dividend announcement. The document is a specific report detailing this corporate action.
2017-05-24 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.